Obesity / weight management clinical trials recruiting in Pennsylvania

63 recruiting obesity / weight management trials match in Pennsylvania. Showing 20.

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Pittsburgh, Pennsylvania

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)Recruiting

  N/A · Penn State University · State College, Pennsylvania

• An Acceptance-Based Healthy Lifestyle Intervention for Diverse AdolescentsRecruiting

  N/A · Nemours Children's Clinic · Philadelphia, Pennsylvania

• Brief Behavioral Sleep Intervention for Obesity Prevention in Primary CareRecruiting

  N/A · Temple University · Philadelphia, Pennsylvania

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)Recruiting

  Phase 4 · Eli Lilly and Company · Plymouth Meeting, Pennsylvania

• Food Genetics Behavior StudyRecruiting

  N/A · University of Pennsylvania · Philadelphia, Pennsylvania

• Feasibility of Semaglutide in Advanced Lung DiseaseRecruiting

  Phase 1 / Phase 2 · University of Pennsylvania · Philadelphia, Pennsylvania

• Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)Recruiting

  N/A · Sean Devitt · Danville, Pennsylvania

• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruiting

  Phase 3 · Novo Nordisk A/S · Escondido, California

• A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · Lincoln, California

• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesRecruiting

  Phase 3 · Ascletis Pharma (China) Co., Limited · Phoenix, Arizona

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · Philadelphia, Pennsylvania

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruiting

  Phase 3 · AstraZeneca · DuBois, Pennsylvania

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting

  Phase 2 · Eli Lilly and Company · Scottdale, Pennsylvania

• Identifying Changes in Food Behaviors Associated With Beginning GLP-1 MedicationRecruiting

  N/A · Penn State University · State College, Pennsylvania

• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesRecruiting

  Phase 3 · Eli Lilly and Company · Pittsburgh, Pennsylvania

• Pharmacogenetics of Response to GLP1R AgonistsRecruiting

  Phase 1 · University of Maryland, Baltimore · Lancaster, Pennsylvania

• Pregnancy 24/7 Offspring StudyRecruiting

  N/A · Kara Whitaker · Iowa City, Iowa

• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have HypercholesterolemiaRecruiting

  Phase 2 · Regeneron Pharmaceuticals · Duncansville, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.